Compile Data Set for Download or QSAR
Report error Found 184 Enz. Inhib. hit(s) with all data for entry = 6507
TargetBeta-secretase 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 134445BDBM134445(US8846658, 164)
Affinity DataIC50: 1nMpH: 4.5 T: 2°CAssay Description:Recombinant BACE-1 (extracellular domain, expressed in baculovirus and purified using standard methods) at 0.1 to 10 nM concentrations is incubated w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/9/2015
Entry Details
US Patent

TargetBeta-secretase 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 134448BDBM134448(US8846658, 167)
Affinity DataIC50: 3nMpH: 4.5 T: 2°CAssay Description:Recombinant BACE-1 (extracellular domain, expressed in baculovirus and purified using standard methods) at 0.1 to 10 nM concentrations is incubated w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/9/2015
Entry Details
US Patent

TargetBeta-secretase 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 134463BDBM134463(US8846658, 182)
Affinity DataIC50: 4nMpH: 4.5 T: 2°CAssay Description:Recombinant BACE-1 (extracellular domain, expressed in baculovirus and purified using standard methods) at 0.1 to 10 nM concentrations is incubated w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/9/2015
Entry Details
US Patent

TargetBeta-secretase 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 18751BDBM18751(US8846658, 92 | US8846658, 93)
Affinity DataIC50: 5nMpH: 4.5 T: 2°CAssay Description:Recombinant BACE-1 (extracellular domain, expressed in baculovirus and purified using standard methods) at 0.1 to 10 nM concentrations is incubated w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/9/2015
Entry Details
US Patent

TargetBeta-secretase 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 134399BDBM134399(US8846658, 114)
Affinity DataIC50: 6nMpH: 4.5 T: 2°CAssay Description:Recombinant BACE-1 (extracellular domain, expressed in baculovirus and purified using standard methods) at 0.1 to 10 nM concentrations is incubated w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/9/2015
Entry Details
US Patent

TargetBeta-secretase 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 19476BDBM19476(US8846658, 44 | US8846658, 115)
Affinity DataIC50: 6nMpH: 4.5 T: 2°CAssay Description:Recombinant BACE-1 (extracellular domain, expressed in baculovirus and purified using standard methods) at 0.1 to 10 nM concentrations is incubated w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/9/2015
Entry Details
US Patent

TargetBeta-secretase 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 134446BDBM134446(US8846658, 165)
Affinity DataIC50: 8nMpH: 4.5 T: 2°CAssay Description:Recombinant BACE-1 (extracellular domain, expressed in baculovirus and purified using standard methods) at 0.1 to 10 nM concentrations is incubated w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/9/2015
Entry Details
US Patent

TargetBeta-secretase 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 18751BDBM18751(US8846658, 92 | US8846658, 93)
Affinity DataIC50: 8nMpH: 4.5 T: 2°CAssay Description:Recombinant BACE-1 (extracellular domain, expressed in baculovirus and purified using standard methods) at 0.1 to 10 nM concentrations is incubated w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/9/2015
Entry Details
US Patent

TargetBeta-secretase 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 134434BDBM134434(US8846658, 153)
Affinity DataIC50: 8nMpH: 4.5 T: 2°CAssay Description:Recombinant BACE-1 (extracellular domain, expressed in baculovirus and purified using standard methods) at 0.1 to 10 nM concentrations is incubated w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/9/2015
Entry Details
US Patent

TargetBeta-secretase 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 134453BDBM134453(US8846658, 172)
Affinity DataIC50: 9nMpH: 4.5 T: 2°CAssay Description:Recombinant BACE-1 (extracellular domain, expressed in baculovirus and purified using standard methods) at 0.1 to 10 nM concentrations is incubated w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/9/2015
Entry Details
US Patent

TargetBeta-secretase 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 134357BDBM134357(US8846658, 69)
Affinity DataIC50: 9nMpH: 4.5 T: 2°CAssay Description:Recombinant BACE-1 (extracellular domain, expressed in baculovirus and purified using standard methods) at 0.1 to 10 nM concentrations is incubated w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/9/2015
Entry Details
US Patent

TargetBeta-secretase 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 50012653BDBM50012653(CHEMBL3261067)
Affinity DataIC50: 10nMpH: 4.5 T: 2°CAssay Description:Recombinant BACE-1 (extracellular domain, expressed in baculovirus and purified using standard methods) at 0.1 to 10 nM concentrations is incubated w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/9/2015
Entry Details
US Patent
PDB3D3D Structure (crystal)
TargetBeta-secretase 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 134402BDBM134402(US8846658, 119)
Affinity DataIC50: 10nMpH: 4.5 T: 2°CAssay Description:Recombinant BACE-1 (extracellular domain, expressed in baculovirus and purified using standard methods) at 0.1 to 10 nM concentrations is incubated w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/9/2015
Entry Details
US Patent

TargetBeta-secretase 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 134356BDBM134356(US8846658, 68)
Affinity DataIC50: 11nMpH: 4.5 T: 2°CAssay Description:Recombinant BACE-1 (extracellular domain, expressed in baculovirus and purified using standard methods) at 0.1 to 10 nM concentrations is incubated w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/9/2015
Entry Details
US Patent

TargetBeta-secretase 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 134441BDBM134441(US8846658, 160)
Affinity DataIC50: 12nMpH: 4.5 T: 2°CAssay Description:Recombinant BACE-1 (extracellular domain, expressed in baculovirus and purified using standard methods) at 0.1 to 10 nM concentrations is incubated w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/9/2015
Entry Details
US Patent

TargetBeta-secretase 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 134450BDBM134450(US8846658, 169)
Affinity DataIC50: 12nMpH: 4.5 T: 2°CAssay Description:Recombinant BACE-1 (extracellular domain, expressed in baculovirus and purified using standard methods) at 0.1 to 10 nM concentrations is incubated w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/9/2015
Entry Details
US Patent

TargetBeta-secretase 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 134401BDBM134401(US8846658, 118)
Affinity DataIC50: 14nMpH: 4.5 T: 2°CAssay Description:Recombinant BACE-1 (extracellular domain, expressed in baculovirus and purified using standard methods) at 0.1 to 10 nM concentrations is incubated w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/9/2015
Entry Details
US Patent

TargetBeta-secretase 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 134378BDBM134378(US8846658, 91)
Affinity DataIC50: 15nMpH: 4.5 T: 2°CAssay Description:Recombinant BACE-1 (extracellular domain, expressed in baculovirus and purified using standard methods) at 0.1 to 10 nM concentrations is incubated w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/9/2015
Entry Details
US Patent

TargetBeta-secretase 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 22021BDBM22021(US8846658, 45 | US8846658, 116)
Affinity DataIC50: 16nMpH: 4.5 T: 2°CAssay Description:Recombinant BACE-1 (extracellular domain, expressed in baculovirus and purified using standard methods) at 0.1 to 10 nM concentrations is incubated w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/9/2015
Entry Details
US Patent

TargetBeta-secretase 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 134359BDBM134359(US8846658, 71)
Affinity DataIC50: 16nMpH: 4.5 T: 2°CAssay Description:Recombinant BACE-1 (extracellular domain, expressed in baculovirus and purified using standard methods) at 0.1 to 10 nM concentrations is incubated w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/9/2015
Entry Details
US Patent

TargetBeta-secretase 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 134456BDBM134456(US8846658, 175)
Affinity DataIC50: 16nMpH: 4.5 T: 2°CAssay Description:Recombinant BACE-1 (extracellular domain, expressed in baculovirus and purified using standard methods) at 0.1 to 10 nM concentrations is incubated w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/9/2015
Entry Details
US Patent

TargetBeta-secretase 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 23140BDBM23140(US8846658, 144 | US8846658, 147)
Affinity DataIC50: 17nMpH: 4.5 T: 2°CAssay Description:Recombinant BACE-1 (extracellular domain, expressed in baculovirus and purified using standard methods) at 0.1 to 10 nM concentrations is incubated w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/9/2015
Entry Details
US Patent

TargetBeta-secretase 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 134383BDBM134383(US8846658, 97)
Affinity DataIC50: 18nMpH: 4.5 T: 2°CAssay Description:Recombinant BACE-1 (extracellular domain, expressed in baculovirus and purified using standard methods) at 0.1 to 10 nM concentrations is incubated w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/9/2015
Entry Details
US Patent

TargetBeta-secretase 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 134400BDBM134400(US8846658, 117)
Affinity DataIC50: 18nMpH: 4.5 T: 2°CAssay Description:Recombinant BACE-1 (extracellular domain, expressed in baculovirus and purified using standard methods) at 0.1 to 10 nM concentrations is incubated w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/9/2015
Entry Details
US Patent

TargetBeta-secretase 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 134457BDBM134457(US8846658, 176)
Affinity DataIC50: 18nMpH: 4.5 T: 2°CAssay Description:Recombinant BACE-1 (extracellular domain, expressed in baculovirus and purified using standard methods) at 0.1 to 10 nM concentrations is incubated w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/9/2015
Entry Details
US Patent

TargetBeta-secretase 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 22021BDBM22021(US8846658, 45 | US8846658, 116)
Affinity DataIC50: 18nMpH: 4.5 T: 2°CAssay Description:Recombinant BACE-1 (extracellular domain, expressed in baculovirus and purified using standard methods) at 0.1 to 10 nM concentrations is incubated w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/9/2015
Entry Details
US Patent

TargetBeta-secretase 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 134439BDBM134439(US8846658, 158)
Affinity DataIC50: 18nMpH: 4.5 T: 2°CAssay Description:Recombinant BACE-1 (extracellular domain, expressed in baculovirus and purified using standard methods) at 0.1 to 10 nM concentrations is incubated w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/9/2015
Entry Details
US Patent

TargetBeta-secretase 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 19476BDBM19476(US8846658, 44 | US8846658, 115)
Affinity DataIC50: 19nMpH: 4.5 T: 2°CAssay Description:Recombinant BACE-1 (extracellular domain, expressed in baculovirus and purified using standard methods) at 0.1 to 10 nM concentrations is incubated w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/9/2015
Entry Details
US Patent

TargetBeta-secretase 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 134354BDBM134354(US8846658, 66)
Affinity DataIC50: 20nMpH: 4.5 T: 2°CAssay Description:Recombinant BACE-1 (extracellular domain, expressed in baculovirus and purified using standard methods) at 0.1 to 10 nM concentrations is incubated w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/9/2015
Entry Details
US Patent
PDB3D3D Structure (crystal)
TargetBeta-secretase 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 134380BDBM134380(US8846658, 94)
Affinity DataIC50: 22nMpH: 4.5 T: 2°CAssay Description:Recombinant BACE-1 (extracellular domain, expressed in baculovirus and purified using standard methods) at 0.1 to 10 nM concentrations is incubated w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/9/2015
Entry Details
US Patent

TargetBeta-secretase 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 134397BDBM134397(US8846658, 111)
Affinity DataIC50: 25nMpH: 4.5 T: 2°CAssay Description:Recombinant BACE-1 (extracellular domain, expressed in baculovirus and purified using standard methods) at 0.1 to 10 nM concentrations is incubated w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/9/2015
Entry Details
US Patent

TargetBeta-secretase 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 134407BDBM134407(US8846658, 124)
Affinity DataIC50: 25nMpH: 4.5 T: 2°CAssay Description:Recombinant BACE-1 (extracellular domain, expressed in baculovirus and purified using standard methods) at 0.1 to 10 nM concentrations is incubated w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/9/2015
Entry Details
US Patent

TargetBeta-secretase 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 134360BDBM134360(US8846658, 73)
Affinity DataIC50: 26nMpH: 4.5 T: 2°CAssay Description:Recombinant BACE-1 (extracellular domain, expressed in baculovirus and purified using standard methods) at 0.1 to 10 nM concentrations is incubated w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/9/2015
Entry Details
US Patent

TargetBeta-secretase 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 134372BDBM134372(US8846658, 85)
Affinity DataIC50: 26nMpH: 4.5 T: 2°CAssay Description:Recombinant BACE-1 (extracellular domain, expressed in baculovirus and purified using standard methods) at 0.1 to 10 nM concentrations is incubated w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/9/2015
Entry Details
US Patent

TargetBeta-secretase 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 134382BDBM134382(US8846658, 96)
Affinity DataIC50: 27nMpH: 4.5 T: 2°CAssay Description:Recombinant BACE-1 (extracellular domain, expressed in baculovirus and purified using standard methods) at 0.1 to 10 nM concentrations is incubated w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/9/2015
Entry Details
US Patent

TargetBeta-secretase 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 134394BDBM134394(US8846658, 108)
Affinity DataIC50: 28nMpH: 4.5 T: 2°CAssay Description:Recombinant BACE-1 (extracellular domain, expressed in baculovirus and purified using standard methods) at 0.1 to 10 nM concentrations is incubated w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/9/2015
Entry Details
US Patent

TargetBeta-secretase 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 134458BDBM134458(US8846658, 177)
Affinity DataIC50: 29nMpH: 4.5 T: 2°CAssay Description:Recombinant BACE-1 (extracellular domain, expressed in baculovirus and purified using standard methods) at 0.1 to 10 nM concentrations is incubated w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/9/2015
Entry Details
US Patent

TargetBeta-secretase 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 134387BDBM134387(US8846658, 101)
Affinity DataIC50: 30nMpH: 4.5 T: 2°CAssay Description:Recombinant BACE-1 (extracellular domain, expressed in baculovirus and purified using standard methods) at 0.1 to 10 nM concentrations is incubated w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/9/2015
Entry Details
US Patent

TargetBeta-secretase 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 134420BDBM134420(US8846658, 137)
Affinity DataIC50: 30nMpH: 4.5 T: 2°CAssay Description:Recombinant BACE-1 (extracellular domain, expressed in baculovirus and purified using standard methods) at 0.1 to 10 nM concentrations is incubated w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/9/2015
Entry Details
US Patent

TargetBeta-secretase 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 134375BDBM134375(US8846658, 88)
Affinity DataIC50: 33nMpH: 4.5 T: 2°CAssay Description:Recombinant BACE-1 (extracellular domain, expressed in baculovirus and purified using standard methods) at 0.1 to 10 nM concentrations is incubated w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/9/2015
Entry Details
US Patent

TargetBeta-secretase 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 134424BDBM134424(US8846658, 141)
Affinity DataIC50: 33nMpH: 4.5 T: 2°CAssay Description:Recombinant BACE-1 (extracellular domain, expressed in baculovirus and purified using standard methods) at 0.1 to 10 nM concentrations is incubated w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/9/2015
Entry Details
US Patent

TargetBeta-secretase 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 134437BDBM134437(US8846658, 156)
Affinity DataIC50: 34nMpH: 4.5 T: 2°CAssay Description:Recombinant BACE-1 (extracellular domain, expressed in baculovirus and purified using standard methods) at 0.1 to 10 nM concentrations is incubated w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/9/2015
Entry Details
US Patent

TargetBeta-secretase 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 134386BDBM134386(US8846658, 100)
Affinity DataIC50: 34nMpH: 4.5 T: 2°CAssay Description:Recombinant BACE-1 (extracellular domain, expressed in baculovirus and purified using standard methods) at 0.1 to 10 nM concentrations is incubated w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/9/2015
Entry Details
US Patent

TargetBeta-secretase 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 134358BDBM134358(US8846658, 70)
Affinity DataIC50: 34nMpH: 4.5 T: 2°CAssay Description:Recombinant BACE-1 (extracellular domain, expressed in baculovirus and purified using standard methods) at 0.1 to 10 nM concentrations is incubated w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/9/2015
Entry Details
US Patent

TargetBeta-secretase 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 134404BDBM134404(US8846658, 121)
Affinity DataIC50: 36nMpH: 4.5 T: 2°CAssay Description:Recombinant BACE-1 (extracellular domain, expressed in baculovirus and purified using standard methods) at 0.1 to 10 nM concentrations is incubated w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/9/2015
Entry Details
US Patent

TargetBeta-secretase 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 134365BDBM134365(US8846658, 78)
Affinity DataIC50: 38nMpH: 4.5 T: 2°CAssay Description:Recombinant BACE-1 (extracellular domain, expressed in baculovirus and purified using standard methods) at 0.1 to 10 nM concentrations is incubated w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/9/2015
Entry Details
US Patent

TargetBeta-secretase 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 134377BDBM134377(US8846658, 90)
Affinity DataIC50: 39nMpH: 4.5 T: 2°CAssay Description:Recombinant BACE-1 (extracellular domain, expressed in baculovirus and purified using standard methods) at 0.1 to 10 nM concentrations is incubated w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/9/2015
Entry Details
US Patent

TargetBeta-secretase 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 134352BDBM134352(US8846658, 64)
Affinity DataIC50: 40nMpH: 4.5 T: 2°CAssay Description:Recombinant BACE-1 (extracellular domain, expressed in baculovirus and purified using standard methods) at 0.1 to 10 nM concentrations is incubated w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/9/2015
Entry Details
US Patent

TargetBeta-secretase 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 50012654BDBM50012654(CHEMBL3261074)
Affinity DataIC50: 42nMpH: 4.5 T: 2°CAssay Description:Recombinant BACE-1 (extracellular domain, expressed in baculovirus and purified using standard methods) at 0.1 to 10 nM concentrations is incubated w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/9/2015
Entry Details
US Patent

TargetBeta-secretase 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 134421BDBM134421(US8846658, 138)
Affinity DataIC50: 42nMpH: 4.5 T: 2°CAssay Description:Recombinant BACE-1 (extracellular domain, expressed in baculovirus and purified using standard methods) at 0.1 to 10 nM concentrations is incubated w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/9/2015
Entry Details
US Patent

Displayed 1 to 50 (of 184 total ) | Next | Last >>
Jump to: